ArticleJournal of arrhythmia2019

Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA-AF-Japan): Three-month interim analysis results.

Takeshi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.